<DOC>
	<DOCNO>NCT01061333</DOCNO>
	<brief_summary>This study assess Early Airway Response ( EAR ) associate change force expiratory volume one second ( FEV1 ) plasma 9α-11ß-PGF2 ( '9P ' ) single dose pretreatment nedocromil , montelukast , mometasone .</brief_summary>
	<brief_title>Early Airway Response Allergen Asthmatics ( MK-0000-176 )</brief_title>
	<detailed_description />
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Nedocromil</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>History mild moderate Asthma In good general health ( except asthma ) Stable free respiratory infection Nonsmoker Females highly unlikely conceive ( surgically sterilize , postmenopausal , agree use 2 acceptable method birth control ) Nursing mother Recent ongoing upper low respiratory tract infection Unable refrain anticipates use prescription nonprescription drug Consumes excessive amount alcohol caffeine History stroke , chronic seizure , major neurological disorder History cancer Received vaccination within past 3 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>